[9]
The second issue to be determined on the motion is whether the Minister should be required, under s. 6(7)(b) of the
Patented Medicines (Notice of Compliance) Regula­tions
, to verify that the portion of the drug master file produced by Apotex to SmithKline corresponds fully to the informa­tion filed with him in the submission for a notice of compliance.